Oncomedics Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 2

Oncomedics General Information

Description

Provider of biotechnology research services intended to make targeted chemotherapy for each patient in order to increase its effectiveness. The company's services predicts the effect of a molecule on a patient's tumor according to the principle of the antibiogram as well as permit oncologists to personalize the treatment by avoiding drugs that are inactive on the cells and by preferring those with strong anti-cancer activity, enabling clinicians and doctors to receive tested drugs and therapies for the immediate treatment of patients suffering from cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • ESTER Technopôle
  • 1 avenue d'Ester
  • 87069 Limoges
  • France
+33 05
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Diagnostic Equipment
Vertical(s)
Corporate Office
  • ESTER Technopôle
  • 1 avenue d'Ester
  • 87069 Limoges
  • France
+33 05

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Oncomedics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Secondary Transaction - Private 01-May-2021 Completed Generating Revenue
5. Later Stage VC 15-May-2019 Completed Generating Revenue
4. Later Stage VC 20-Dec-2017 Completed Generating Revenue
3. Equity Crowdfunding 01-Jul-2016 Completed Generating Revenue
2. Secondary Transaction - Private Completed Startup
1. Early Stage VC Completed Startup
To view Oncomedics’s complete valuation and funding history, request access »

Oncomedics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
To view Oncomedics’s complete cap table history, request access »

Oncomedics Patents

Oncomedics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4381474-A1 Cell counting method and method for determining the efficacy of a drug candidate Pending 04-Aug-2021
US-20240344011-A1 Cell counting method and method for determining the efficacy of a drug candidate Pending 04-Aug-2021
EP-4376836-A1 Compositions and methods for decontaminating and culturing a gastrointestinal tract sample Pending 30-Jul-2021
US-20240368558-A1 Compositions and methods for decontaminating and culturing a gastrointestinal tract sample Pending 30-Jul-2021
US-20160320316-A1 Method for determining the cell aggressiveness grade of cancer cells or of cancer stem cells Inactive 24-Dec-2013 G01N22/00
To view Oncomedics’s complete patent history, request access »

Oncomedics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Oncomedics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
AQUITI Gestion PE/Buyout Minority
Limousin Business Angels Angel Group Minority
To view Oncomedics’s complete investors history, request access »

Oncomedics FAQs

  • When was Oncomedics founded?

    Oncomedics was founded in 2006.

  • Where is Oncomedics headquartered?

    Oncomedics is headquartered in Limoges, France.

  • What is the size of Oncomedics?

    Oncomedics has 8 total employees.

  • What industry is Oncomedics in?

    Oncomedics’s primary industry is Biotechnology.

  • Is Oncomedics a private or public company?

    Oncomedics is a Private company.

  • What is Oncomedics’s current revenue?

    The current revenue for Oncomedics is .

  • How much funding has Oncomedics raised over time?

    Oncomedics has raised $1.18M.

  • Who are Oncomedics’s investors?

    AQUITI Gestion and Limousin Business Angels have invested in Oncomedics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »